BIOGEN INC
BIIB · NASDAQ
Updated at 2026-10-14 08:10:33
- Today's High
- $231.03
- Today’s Low
- $226.71
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $233.98
- Previous Close
- $229.41
- Volume
- 1.46M
- Market Cap
- $33.89B
- P/E Ratio
- 41.51X
- EPS
- $5.64
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- DRUG MANUFACTURERS - GENERAL
- Headquarters
- 225 BINNEY STREET, CAMBRIDGE, MA, UNITED STATES, 02142
- Country
- US
- Listing Date
- 1991-09-17
- Fiscal Year End
- December
- Shares Outstanding
- 147.75M
- CIK
- 0000875045
- Website
- www.biogen.com
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
Financial Metrics
Revenue
2026-06-30
$2.73B
2026-03-31
$2.47B
2025-12-31
$2.27B
2025-09-30
$2.45B
Operating Expenses
2026-06-30
$1.23B
2026-03-31
$1.41B
2025-12-31
$1.84B
2025-09-30
$964.4M
Net Income
2026-06-30
$97.5M
2026-03-31
$319.5M
2025-12-31
-$48.41M
2025-09-30
$466.5M
Net Profit Margin
2026-06-30
3.56%
2026-03-31
12.89%
2025-12-31
-2.12%
2025-09-30
19%
Earnings Per Share
2026-06-30
$3.60
2026-03-31
$3.57
2025-12-31
$1.99
2025-09-30
$4.81
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$450.8M
2026-03-31
$621.5M
2025-12-31
$56.7M
2025-09-30
$826.9M
Effective Tax Rate
2026-06-30
26.35%
2026-03-31
15.4%
2025-12-31
77.05%
2025-09-30
16.29%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $2.73B | $2.47B | $2.27B | $2.45B |
| Operating Expenses | $1.23B | $1.41B | $1.84B | $964.4M |
| Net Income | $97.5M | $319.5M | -$48.41M | $466.5M |
| Net Profit Margin | 3.56% | 12.89% | -2.12% | 19% |
| Earnings Per Share | $3.60 | $3.57 | $1.99 | $4.81 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $450.8M | $621.5M | $56.7M | $826.9M |
| Effective Tax Rate | 26.35% | 15.4% | 77.05% | 16.29% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations. Trading related derivatives may involve leveraged losses, liquidation, and liquidity risks. Review product rules carefully before trading.